share_log

亨迪药业:2023年年度股东大会法律意见书

Hubei Biocause Heilen Pharmaceutical: 2023 Annual General Meeting of Shareholders Legal Opinions

SZSI ·  May 14
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more